Thrombospondin
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
== Relevance == | == Relevance == | ||
TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>. | TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>. | ||
| + | |||
| + | == Disease == | ||
| + | TSP-2 mutation is associated with coronary artery disease<ref>PMID:18499674</ref>. | ||
| + | |||
== Structural highlights == | == Structural highlights == | ||
Revision as of 11:55, 20 December 2016
| |||||||||||
3D structures of thrombospondin
Updated on 20-December-2016
References
- ↑ Adams JC. Thrombospondin-1. Int J Biochem Cell Biol. 1997 Jun;29(6):861-5. PMID:9304800
- ↑ Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med. 2012 May;2(5):a006627. doi:, 10.1101/cshperspect.a006627. PMID:22553494 doi:http://dx.doi.org/10.1101/cshperspect.a006627
- ↑ Carlson CB, Liu Y, Keck JL, Mosher DF. Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability. J Biol Chem. 2008 Jul 18;283(29):20069-76. Epub 2008 May 22. PMID:18499674 doi:10.1074/jbc.M800223200
